ST段抬高型心肌梗死介入治疗门球时间与结局的荟萃分析
结果显示门球时间>90分钟与短期死亡(合并OR 1.52,95%CI 1.40-1.65)及中远期死亡(合并OR 1.53,95%CI 1.13-2.06)风险升高相关,且时间-风险关系呈非线性(P=0.004),院前延迟可修饰该效应。
要点
- 门球时间>90分钟与短期及中远期死亡风险升高相关。
- 时间-风险关系呈非线性,院前延迟较短者门球延迟影响更强。
- 院前延迟可修饰门球延迟与短期死亡的关联。
核心结论
- ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中,较长的门球延迟与不良结局风险升高相关。
- 院前延迟可修饰门球延迟与短期死亡的关联。
- 时间-风险关系的非线性可能解释美国门球时间改善但人群效应缺乏的现象。
研究设计与样本
- 主要结局包括死亡和心力衰竭。
主要发现
- 门球延迟>90分钟者短期死亡合并OR 1.52(95%CI 1.40-1.65)。
- 门球延迟>90分钟者中远期死亡合并OR 1.53(95%CI 1.13-2.06)。
- 时间-风险关系非线性(P=0.004)。
- 院前延迟早与晚者短期死亡关联不同(Cochran's Q 3.88,P=0.049),院前延迟较短者关联更强。
临床怎么用
- 对ST段抬高型心肌梗死患者应关注门球时间,尤其院前延迟较短者。
- 改善门球时间的同时需考虑时间-风险非线性及院前延迟的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aims to determine the relationship between door-to-balloon delay in primary percutaneous coronary intervention and ST-elevation myocardial infarction (MI) outcomes and examine for potential effect modifiers. METHODS: We conducted a systematic review and meta-analysis of prospective observational studies that have investigated the relationship of door-to-balloon delay and clinical outcomes. The main outcomes include mortality and heart failure. RESULTS: 32 studies involving 299 320 patients contained adequate data for quantitative reporting. Patients with ST-elevation MI who experienced longer (>90 min) door-to-balloon delay had a higher risk of short-term mortality (pooled OR 1.52, 95% CI 1.40 to 1.65) and medium-term to long-term mortality (pooled OR 1.53, 95% CI 1.13 to 2.06). A non-linear time-risk relation was observed (P=0.004 for non-linearity). The association between longer door-to-balloon delay and short-term mortality differed between those presented early and late after symptom onset (Cochran's Q 3.88, P value 0.049) with a stronger relationship among those with shorter prehospital delays. CONCLUSION: Longer door-to-balloon delay in primary percutaneous coronary intervention for ST-elevation MI is related to higher risk of adverse outcomes. Prehospital delays modified this effect. The non-linearity of the time-risk relation might explain the lack of population effect despite an improved door-to-balloon time in the USA. CLINICAL TRIAL REGISTRATION: PROSPERO (CRD42015026069).
引用
- Foo CY, Bonsu KO, Nallamothu BK, et al. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart. 2018. PMID: 29437704. doi:10.1136/heartjnl-2017-312517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。